z-logo
open-access-imgOpen Access
Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas
Author(s) -
Sarah J. Richardson,
Pia Leete,
Shalinee Dhayal,
Mark A. Russell,
Maarit Oikarinen,
Jutta E. Laiho,
Emma Svedin,
Katharina Lind,
Therese Rosenling,
Nora M. Chapman,
Adrian J. Bone,
Alan K. Foulis,
Gun Frisk,
Malin FlodströmTullberg,
Didier Hober,
Heikki Hyöty,
Noel G. Morgan
Publication year - 2013
Publication title -
diabetologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.464
H-Index - 227
eISSN - 1432-0428
pISSN - 0012-186X
DOI - 10.1007/s00125-013-3094-7
Subject(s) - biology , clone (java method) , microbiology and biotechnology , virology , monoclonal antibody , pancreas , blot , antibody , immunology , gene , genetics , biochemistry
Enteroviral infection has been implicated in the development of islet autoimmunity in type 1 diabetes and enteroviral antigen expression has been detected by immunohistochemistry in the pancreatic beta cells of patients with recent-onset type 1 diabetes. However, the immunohistochemical evidence relies heavily on the use of a monoclonal antibody, clone 5D8/1, raised against an enteroviral capsid protein, VP1. Recent data suggest that the clone 5D8/1 may also recognise non-viral antigens; in particular, a component of the mitochondrial ATP synthase (ATP5B) and an isoform of creatine kinase (CKB). Therefore, we evaluated the fidelity of immunolabelling by clone 5D8/1 in the islets of patients with type 1 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom